Page last updated: 2024-10-31

deoxyepinephrine and Uveitis

deoxyepinephrine has been researched along with Uveitis in 3 studies

Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.

Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"To study whether topical ibopamine effectively increases the intraocular pressure in patients with ocular hypotony after vitreoretinal surgery, uveitis, or penetrating trauma."9.12Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. ( Cohen, AC; Ganteris, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC; Veckeneer, M, 2006)
"To evaluate the effectiveness of 6 months treatment with ibopamine eye drops in raising the intraocular pressure in patients with therapy-resistant hypotony after vitreoretinal surgery for proliferative vitreoretinopathy secondary to rhegmatogenous retinal detachment or penetrating trauma."7.78Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma. ( Cohen, AF; Ganteris-Gerritsen, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC, 2012)
"Ibopamine 2 % eye drops in combination with topical steroids are a therapeutic option in uveitis-associated ocular hypotony."7.73[Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine]. ( Iliev, ME; Windisch, BK, 2006)
"To study whether topical ibopamine effectively increases the intraocular pressure in patients with ocular hypotony after vitreoretinal surgery, uveitis, or penetrating trauma."5.12Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. ( Cohen, AC; Ganteris, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC; Veckeneer, M, 2006)
"To evaluate the effectiveness of 6 months treatment with ibopamine eye drops in raising the intraocular pressure in patients with therapy-resistant hypotony after vitreoretinal surgery for proliferative vitreoretinopathy secondary to rhegmatogenous retinal detachment or penetrating trauma."3.78Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma. ( Cohen, AF; Ganteris-Gerritsen, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC, 2012)
"Ibopamine 2 % eye drops in combination with topical steroids are a therapeutic option in uveitis-associated ocular hypotony."3.73[Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine]. ( Iliev, ME; Windisch, BK, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ganteris-Gerritsen, E1
Ugahary, LC2
Jansen, J2
Mulder, PG2
Cohen, AF1
van Meurs, JC2
Ganteris, E1
Veckeneer, M1
Cohen, AC1
Windisch, BK1
Iliev, ME1

Trials

1 trial available for deoxyepinephrine and Uveitis

ArticleYear
Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
    American journal of ophthalmology, 2006, Volume: 141, Issue:3

    Topics: Administration, Topical; Adult; Aged; Chronic Disease; Cross-Over Studies; Deoxyepinephrine; Dopamin

2006

Other Studies

2 other studies available for deoxyepinephrine and Uveitis

ArticleYear
Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma.
    Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Eye Injuries,

2012
[Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine].
    Klinische Monatsblatter fur Augenheilkunde, 2006, Volume: 223, Issue:5

    Topics: Administration, Topical; Chronic Disease; Deoxyepinephrine; Humans; Male; Mydriatics; Ocular Hypoten

2006